Guoyun Kao

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Rational design of humanized antibody inhibitors for cathepsin S”.

Rational design of humanized antibody inhibitors for cathepsin S

Archives of Biochemistry and Biophysics(2023)10.1016/j.abb.2023.109849

N/A

0DataRank · unranked

12 citations

Guoyun Kao, Zhefu Dai, Fariborz Nasertorabi, Yong Zhang, Po-Wen Yu

Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemia

Molecular Therapy(2025)10.1016/j.ymthe.2025.01.025

N/A

0DataRank · unranked

10 citations

Guoyun Kao, Yuanteng Zhao, Zeyu Zhang, Hyo Sun Kim, Xiaojing Shi +5 more

Synthesis of Bispecific Conjugates by ADP‐Ribosyl Cyclases

Advanced Science(2025)10.1002/advs.202518329

N/A

0DataRank · unranked

2 citations

Arshad J. Ansari, Lei Zhang, Guoyun Kao, Thuc Oanh Hoang, Zeyu Zhang +4 more

Preclinical assessment of genetically modified exosomes for colorectal cancer immunotherapy

Journal of Controlled Release(2025)10.1016/j.jconrel.2025.114425

N/A

0DataRank · unranked

2 citations

Lei Zhang, Sunny H. Kim, Guoyun Kao, Kaiyu Shen, Zeyu Zhang +4 more

Targeting prostate cancer with site-specific antibody-drug conjugates enabled by tandemly fused ADP-ribosyl cyclases

Biomedicine & Pharmacotherapy(2025)10.1016/j.biopha.2025.118274

N/A

0DataRank · unranked

2 citations

Mashael F Aldossari, Arshad J. Ansari, Guoyun Kao, Sunny H. Kim, Thuc Oanh Hoang +11 more